When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...
An historic settlement reached between drugmakers and some states offers those states which were part of the deal a valuable ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Less than two months since free naloxone kiosks debuted around the region, community members have taken more than 1,200 boxes ...
Data I’ve collected show that while awareness about opioid antagonists is growing, there’s still a significant knowledge gap. In a national sample, around one-third of college students knew ...
Young, urban and poor women in Puerto Rico are highly vulnerable to substance dependency and suffer most in the opioid crisis ...
But before allocating the money, most of those decision-makers won’t have to consult those most impacted by the opioid ...
Candidate genetic variants included in a genetic risk algorithm may not meet standards of reasonable clinical efficacy in identifying opioid use disorder risk, according to a study published in JAMA ...
Researchers at University of the Pacific in Stockton have developed a long-acting opioid overdose-reversal drug-delivery system that could save lives.
Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and ...
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.